DaVita Clinical Research Study Finds Efficacy of Common COVID-19 Vaccines at Parity for Kidney Patients
- Thursday, February 17, 2022, 6:35
- Environment
- Add a comment
DENVER, Feb. 17, 2022 /PRNewswire/ — Dialysis patients who received an adenovirus vector-based COVID-19 vaccine (Johnson & Johnson) were found to have similar rates of breakthrough infection, hospitalization and mortality as dialysis patients who received an mRNA-based vaccine…
About the Author
adminasapcorp has written 41821 stories on this site.